INTS
USDIntensity Therapeutics Inc. Common stock
$0.455-0.035 (-7.122%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.490
High
$0.503
Low
$0.430
Volume
14.52M
Company Fundamentals
Market Cap
27.3M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
30.37M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.185Current $0.455High $3.399
Related News
PR Newswire
Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal
Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and...
View more
Related Stocks
HCA
HCA Healthcare Inc.
NASDAQ
Hospital/Nursin...
IPXXU
Inflection Point Acquisition Corp. II Unit
NASDAQ
Blank Checks
FLNC
Fluence Energy Inc.
NASDAQ
Industrial Mach...
AOGOU
Arogo Capital Acquisition Corp. Unit
NASDAQ
Computer Softwa...
UE
Urban Edge Properties Common Shares of Beneficial Interest
NASDAQ
Real Estate
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.